Chronic cough, a persistent and debilitating condition, poses a significant challenge in clinical practice due to its multifactorial nature. Understanding its complexity and refining diagnostic and management strategies are essential for optimal patient outcomes.
Chronic cough can result from a myriad of conditions including chronic obstructive pulmonary disease (COPD), gastroesophageal reflux disease (GERD), and postnasal drip syndrome. It's crucial to perform a comprehensive clinical assessment, including a detailed history and physical examination, to identify potential causes and guide further diagnostic testing.
A stepwise approach is recommended for diagnosing chronic cough. Initial investigations should focus on common causes, using tests such as spirometry, chest X-ray, and upper airway endoscopy. If these tests are inconclusive, more advanced diagnostic modalities, including high-resolution computed tomography and bronchoscopy, may be warranted. Additionally, empirical therapy trials can be used to diagnose conditions like GERD and asthma, where diagnostic tests may lack sensitivity.
Treatment should be tailored to the underlying cause identified. For example, inhaled corticosteroids may be beneficial in cough-variant asthma, while proton pump inhibitors can be used in GERD-associated cough. In refractory cases, multidisciplinary input may be necessary. Non-pharmacological interventions, such as speech therapy and behavioral techniques, have also shown promise in managing unexplained chronic cough.
Despite advances, chronic cough remains a complex condition with significant diagnostic and therapeutic challenges. Future research should focus on refining diagnostic criteria, developing novel therapeutic agents, and understanding the pathophysiology of unexplained chronic cough. Additionally, more emphasis on patient-centered outcomes and quality of life measures is needed.
Chronic cough represents a complex clinical problem requiring a comprehensive approach for effective diagnosis and management. By refining our understanding and approach, we can improve patient outcomes, reduce healthcare utilization, and advance the field of cough research.
1.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
1.
Learning from Uncommon Inherited Bleeding Disorder Presentations
2.
Essential Strategies in Hematology for Healthcare Excellence
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
5.
Lymphomatoid Papulosis: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation